Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Denali Therapeutics Insider Sold Shares Worth $261,929, According to a Recent SEC Filing

Denali Therapeutics Insider Sold Shares Worth $261,929, According to a Recent SEC Filing

MT newswireMT newswire2026/09/04 21:12
05:12 PM EDT, 09/04/2026 (MT Newswires) -- Nancy Thornberry, Director, on September 02, 2026, sold 11,439 shares in Denali Therapeutics (DNLI) for $261,929. Following the Form 4 filing with the SEC, Thornberry has control over a total of 19,686 common shares of the company, with 19,686 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1714899/000179782626000006/xslF345X05/wk-form4_1788555742.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!